The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
His resignation would be effective from March 18, 2024
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
The market capitalization of the company stood at Rs. 7,000 crore +
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Subscribe To Our Newsletter & Stay Updated
